Aprea Therapeutics, Inc. insider trading
APRE$0.70-0.03 (-4.01% today)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-53.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Unlock quarterly net flowKey players
- OGOren Gilad3.1426%
- MDMarc Duey2.0641%
- BRBernd R. Seizinger0.3884%
- JPJohn P. Hamill0.3457%
- RPRifat Pamukcu0.1802%
- JBJohn B. Henneman III0.1061%
- RPRichard Peters0.0497%
- MGMichael Grissinger0.0478%
- GGGabriela Gruia0.0332%
- JBJean-Pierre Bizzari0.0332%
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| APRE | Oren Gilad | Open market purchase$25K | +8.1% | $0.89 | $25K | Jan 30, 2026 | Feb 2, 2026 |
| APRE | John P. Hamill | Open market purchase$5.07K | +20.6% | $0.89 | $5.07K | Jan 30, 2026 | Feb 2, 2026 |
| APRE | Marc Duey | Open market purchase$25.1K | +9.1% | $1.17 | $25.1K | Dec 10, 2025 | Dec 11, 2025 |
| APRE | John P. Hamill | Open market purchase$5.85K | +22.0% | $1.17 | $5.85K | Dec 10, 2025 | Dec 11, 2025 |